Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.
Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:
- a review of the information gathered on the shortage issue, and
- a thorough discussion on its potential impact and next steps.
Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
CYTOVENE | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 500MG | Updated Report | 2023-03-31 | 184528 |
ONE-ALPHA | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 2MCG | Updated Report | 2023-03-31 | 180961 |
KEVZARA | SANOFI-AVENTIS CANADA INC | Anticipated shortage | 200MG | New Report | 2023-03-31 | 188465 |
FLAGYL | SANOFI-AVENTIS CANADA INC | Resolved | 10% | Updated Report | 2023-03-31 | 186612 |
!!T3 FLUDARA | SANOFI-AVENTIS CANADA INC | Actual shortage | 10MG | Updated Report | 2023-03-31 | 167783 |
GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | Actual shortage | 850MG | Updated Report | 2023-03-31 | 178385 |
METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Anticipated shortage | 25MG | Updated Report | 2023-03-31 | 188454 |
DEXTROSE INJECTION | OMEGA LABORATORIES LIMITED | Actual shortage | 50% | Updated Report | 2023-03-31 | 182591 |
DILTIAZEM HYDROCHLORIDE INJECTION | OMEGA LABORATORIES LIMITED | Actual shortage | 5MG | Updated Report | 2023-03-31 | 187972 |
RIVOTRIL | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 0.5MG | Updated Report | 2023-03-31 | 171577 |
RIVOTRIL | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 2MG | Updated Report | 2023-03-31 | 171580 |
DIPENTUM | ATNAHS PHARMA UK LIMITED | Actual shortage | 250MG | Updated Report | 2023-03-31 | 188443 |
DEXAMETHASONE OMEGA UNIDOSE | OMEGA LABORATORIES LIMITED | Resolved | 10MG | Updated Report | 2023-03-31 | 187964 |
IMITREX | GLAXOSMITHKLINE INC | Resolved | 6MG | Updated Report | 2023-03-31 | 179840 |
IPRAVENT | AA PHARMA INC | Resolved | 42MCG | Updated Report | 2023-03-31 | 186512 |
SYNJARDY | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Actual shortage | 500MG 12.5MG | Updated Report | 2023-03-31 | 187797 |
KETOROLAC | AA PHARMA INC | Actual shortage | 0.5% | Updated Report | 2023-03-31 | 188326 |
MISOPROSTOL | AA PHARMA INC | Actual shortage | 100MCG | Updated Report | 2023-03-31 | 188329 |
0.9% SODIUM CHLORIDE IRRIGATION, USP | BAXTER CORPORATION | Resolved | 900MG | Updated Report | 2023-03-31 | 181191 |
0.9% SODIUM CHLORIDE IRRIGATION, USP | BAXTER CORPORATION | Resolved | 900MG | Updated Report | 2023-03-31 | 181393 |
5% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Resolved | 5G | Updated Report | 2023-03-31 | 187084 |
FOQUEST | ELVIUM LIFE SCIENCES | Actual shortage | 55MG | Updated Report | 2023-03-31 | 188286 |
APO-ESOMEPRAZOLE | APOTEX INC | Actual shortage | 40MG | Updated Report | 2023-03-30 | 188427 |
APO-ALLOPURINOL | APOTEX INC | Actual shortage | 200MG | New Report | 2023-03-30 | 188424 |
APO-ZOPICLONE | APOTEX INC | Actual shortage | 7.5MG | New Report | 2023-03-30 | 188421 |
APO PREDNISONE TAB 50MG | APOTEX INC | Actual shortage | 50MG | New Report | 2023-03-30 | 188418 |
APO-SITAGLIPTIN MALATE | APOTEX INC | Actual shortage | 50MG | Updated Report | 2023-03-30 | 188415 |
APO-SITAGLIPTIN MALATE | APOTEX INC | Actual shortage | 100MG | Updated Report | 2023-03-30 | 188411 |
APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Actual shortage | 1000MG 50MG | Updated Report | 2023-03-30 | 185982 |
APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Actual shortage | 1000MG 50MG | Updated Report | 2023-03-30 | 185976 |
APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Actual shortage | 1000MG 50MG | Updated Report | 2023-03-30 | 185973 |
APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Actual shortage | 500MG 50MG | Updated Report | 2023-03-30 | 185970 |
APO-SITAGLIPTIN MALATE | APOTEX INC | Actual shortage | 25MG | Updated Report | 2023-03-30 | 184112 |
APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Actual shortage | 1000MG 100MG | Updated Report | 2023-03-30 | 185985 |
APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Actual shortage | 1000MG 100MG | Updated Report | 2023-03-30 | 185967 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Actual shortage | 1000MG 50MG | Updated Report | 2023-03-30 | 185964 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Actual shortage | 1000MG 50MG | Updated Report | 2023-03-30 | 185961 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Actual shortage | 1000MG 50MG | Updated Report | 2023-03-30 | 185957 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Actual shortage | 850MG 50MG | Updated Report | 2023-03-30 | 185954 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Actual shortage | 850MG 50MG | Updated Report | 2023-03-30 | 185951 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Actual shortage | 500MG 50MG | Updated Report | 2023-03-30 | 180124 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Actual shortage | 500MG 50MG | Updated Report | 2023-03-30 | 185948 |
APO-RASAGILINE | APOTEX INC | Actual shortage | 1MG | Updated Report | 2023-03-30 | 187244 |
APO-SOTALOL | APOTEX INC | Actual shortage | 160MG | Updated Report | 2023-03-30 | 186569 |
APO-NAPROXEN | APOTEX INC | Actual shortage | 500MG | Updated Report | 2023-03-30 | 185459 |
APO-OLANZAPINE | APOTEX INC | Actual shortage | 20MG | Updated Report | 2023-03-30 | 184097 |
APO-OXYBUTYNIN | APOTEX INC | Actual shortage | 5MG | Updated Report | 2023-03-30 | 183474 |
APO-OXYBUTYNIN | APOTEX INC | Actual shortage | 5MG | Updated Report | 2023-03-30 | 187229 |
TRI-CIRA LO 21 | APOTEX INC | Actual shortage | 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG | Updated Report | 2023-03-30 | 172942 |
APO-RALOXIFENE | APOTEX INC | Actual shortage | 60MG | Updated Report | 2023-03-30 | 181104 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
HIBERIX | GLAXOSMITHKLINE INC | Discontinued | 10MCG | Updated Report | 2023-03-29 | 175258 |
OMNISCAN | GE HEALTHCARE CANADA INC | Discontinued | 287MG | Updated Report | 2023-03-25 | 182742 |
QUININE - ODAN | ODAN LABORATORIES LTD | Discontinued | 200MG | New Report | 2023-03-22 | 187637 |
FLAGYL | ODAN LABORATORIES LTD | Discontinued | 500MG | New Report | 2023-03-22 | 187634 |
NOLVADEX-D TAB 20MG | ASTRAZENECA CANADA INC | Discontinued | 20MG | Updated Report | 2023-03-22 | 170947 |
OMNIPAQUE 240 | GE HEALTHCARE CANADA INC | Discontinued | 518MG | Updated Report | 2023-03-18 | 182760 |
GLUCAGON | ELI LILLY CANADA INC | To be discontinued | 1MG | Updated Report | 2023-03-14 | 165759 |
ZOFRAN ODT | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 4MG | New Report | 2023-03-14 | 187062 |
ZOFRAN ODT | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 8MG | Updated Report | 2023-03-14 | 177540 |
STRATTERA | ELI LILLY CANADA INC | To be discontinued | 40MG | Updated Report | 2023-03-01 | 171488 |